Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same
US-2024358697-A1 · Oct 31, 2024 · US
This page is not indexed by search engines while we improve data quality.
Chen Ming J patents
Chen Ming J is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Chen Ming J |
| Total patents | 13 |
| First publication | May 5, 2015 |
| Latest publication | Oct 31, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same
US-12064427-B2 · Aug 20, 2024 · US
Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same
US-2024066026-A1 · Feb 29, 2024 · US
Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using the
US-11779580-B2 · Oct 10, 2023 · US
Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same
US-2020215061-A1 · Jul 9, 2020 · US
Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
US-9757355-B2 · Sep 12, 2017 · US
Nanosuspension of a poorly soluble drug via microfluidization process
US-9616019-B2 · Apr 11, 2017 · US
Controlled release oral dosage forms of poorly soluble drugs and uses thereof
US-9532977-B2 · Jan 3, 2017 · US
Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
US-9434735-B2 · Sep 6, 2016 · US
Controlled release oral dosage forms of poorly soluble drugs and uses thereof
US-2016128981-A1 · May 12, 2016 · US
Recent patents
Latest publications not already listed above.
Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
US-2016009722-A1 · Jan 14, 2016 · US
Nanosuspension of a poorly soluble drug via microfluidization process
US-2015265534-A1 · Sep 24, 2015 · US
Nanosuspension of a poorly soluble drug via microfluidization process
US-9023886-B2 · May 5, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Celgene Corp | 11 |
| Chen Ming J | 2 |
| Hui Ho-Wah | 2 |
| Lee Thomas | 2 |
| Kurtulik Paul | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 11 |
| A61K9/0053 | 10 |
| A61K31/4035 | 6 |
| A61K9/4858 | 6 |
| A61K9/4866 | 6 |